Related references
Note: Only part of the references are listed.Discovery and characterization of potent And-1 inhibitors for cancer treatment
Jing Li et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex
Michael F. Sharp et al.
SCIENTIFIC REPORTS (2020)
Fanconi anemia pathway as a prospective target for cancer intervention
Wenjun Liu et al.
CELL AND BIOSCIENCE (2020)
WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
Ayse Ertay et al.
CELL DEATH & DISEASE (2020)
MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma
Bo Liu et al.
DIGESTIVE AND LIVER DISEASE (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2
Jing Huang et al.
CELL REPORTS (2019)
SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair
Huimin Zhang et al.
NUCLEIC ACIDS RESEARCH (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Giovanna Damia et al.
CANCERS (2019)
SIRF: Quantitative in situ analysis of protein interactions at DNA replication forks
Sunetra Roy et al.
JOURNAL OF CELL BIOLOGY (2018)
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
Wei Zhou et al.
ONCOGENE (2018)
A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links
Alex M. Andrews et al.
NATURE COMMUNICATIONS (2018)
AND-1 fork protection function prevents fork resection and is essential for proliferation
Takuya Abe et al.
NATURE COMMUNICATIONS (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
And-1 coordinates with CtIP for efficient homologous recombination and DNA damage checkpoint maintenance
Yali Chen et al.
NUCLEIC ACIDS RESEARCH (2017)
And-1 is required for homologous recombination repair by regulating DNA end resection
Yongming Li et al.
NUCLEIC ACIDS RESEARCH (2017)
The structure and polymerase-recognition mechanism of the crucial adaptor protein AND-1 in the human replisome
Chengcheng Guan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene
Ed Dicks et al.
ONCOTARGET (2017)
Ctf4 Links DNA Replication with Sister Chromatid Cohesion Establishment by Recruiting the Chl1 Helicase to the Replisome
Catarina P. Samora et al.
MOLECULAR CELL (2016)
FANCM interacts with PCNA to promote replication traverse of DNA interstrand crosslinks
Florian Rohleder et al.
NUCLEIC ACIDS RESEARCH (2016)
And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress
Jing Hao et al.
EMBO JOURNAL (2015)
Tissue-aware data integration approach for the inference of pathway interactions in metazoan organisms
Christopher Y. Park et al.
BIOINFORMATICS (2015)
A Ctf4 trimer couples the CMG helicase to DNA polymerase α in the eukaryotic replisome
Aline C. Simon et al.
NATURE (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions
Yucai Wang et al.
MOLECULAR CELL (2013)
Saccharomyces cerevisiae Genetics Predicts Candidate Therapeutic Genetic Interactions at the Mammalian Replication Fork
Derek M. van Pel et al.
G3-GENES GENOMES GENETICS (2013)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
The Involvement of Acidic Nucleoplasmic DNA-binding Protein (And-1) in the Regulation of Prereplicative Complex (pre-RC) Assembly in Human Cells
Yongming Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Celine Jacquemont et al.
MOLECULAR CANCER (2012)
DNA interstrand crosslink repair and cancer
Andrew J. Deans et al.
NATURE REVIEWS CANCER (2011)
Activation of WD Repeat and High-Mobility Group Box DNA Binding Protein 1 in Pulmonary and Esophageal Carcinogenesis
Nagato Sato et al.
CLINICAL CANCER RESEARCH (2010)
MHF1-MHF2, a Histone-Fold-Containing Protein Complex, Participates in the Fanconi Anemia Pathway via FANCM
Thiyam Ramsing Singh et al.
MOLECULAR CELL (2010)
A Histone-Fold Complex and FANCM Form a Conserved DNA-Remodeling Complex to Maintain Genome Stability
Zhijiang Yan et al.
MOLECULAR CELL (2010)
Replisome progression complex links DNA replication to sister chromatid cohesion in Xenopus egg extracts
Hiroshi Tanaka et al.
GENES TO CELLS (2009)
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
Igor Landais et al.
MOLECULAR CANCER (2009)
Fanconi anemia and its diagnosis
Arleen D. Auerbach
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Puck Knipscheer et al.
SCIENCE (2009)
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy
P. Wynne et al.
BRITISH JOURNAL OF CANCER (2007)
Mcm10 and And-1/CTF4 recruit DNA polymerase α to chromatin for initiation of DNA replication
Wenge Zhu et al.
GENES & DEVELOPMENT (2007)
Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM
Alberto Ciccia et al.
MOLECULAR CELL (2007)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.: Part 1:: Cellular pharmacology, in vitro and initial in vivo antitumor activity
JA Hartley et al.
CANCER RESEARCH (2004)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
The Fanconi anemia pathway and the DNA interstrand cross-links repair
F Rosselli et al.
BIOCHIMIE (2003)
Protein disorder prediction: Implications for structural proteomics
R Linding et al.
STRUCTURE (2003)
Share Paper
